{"id":"W4295549046","doi":"10.3390/antibiotics11091234","title":"SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)","year":2022,"lang":"en","type":"review","venue":"Antibiotics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Seres Therapeutics; European Tissue Symposium; Da Volterra; Nabriva Therapeutics; Pfizer","keywords":"Clostridioides; Microbiome; Investigational Drugs; Medicine; Internal medicine; Biology; Bioinformatics; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003640013,0.0007313386,0.001651932,0.0005652805,0.0004051335,0.0001095334,0.0002928241,0.0004118102,0.0003098931],"category_scores_gemma":[0.0001659533,0.0005713953,0.0005788513,0.001036213,0.0002300218,0.0001215379,0.0001606164,0.0009626791,0.00004388115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007759486,"about_ca_system_score_gemma":0.00139494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005983821,"about_ca_topic_score_gemma":0.00002675441,"domain_scores_codex":[0.996452,0.0002375087,0.0008447975,0.0009101794,0.0008290918,0.0007264392],"domain_scores_gemma":[0.9978077,0.0003312721,0.000433992,0.0007403249,0.0003276721,0.0003590697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004914395,0.003598537,0.00233001,0.0188899,0.00101805,0.00002321141,0.00006146096,0.000006158983,0.00008328398,0.0001928992,0.002447201,0.9708579],"study_design_scores_gemma":[0.001820868,0.004570378,0.0004658428,0.00297405,0.001992194,0.00006075898,0.00001837706,0.00006133693,0.0003496007,0.00001559103,0.9869612,0.0007097677],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08467092,0.9040464,0.00007547511,0.0001065694,0.001099738,0.007160559,0.002378326,0.0002584597,0.0002035261],"genre_scores_gemma":[0.003783979,0.9780153,0.0004685724,0.0001076325,0.0005201372,0.00004352152,0.01643491,0.0002313417,0.0003946186],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9845141,"threshold_uncertainty_score":0.9996737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08859999749977797,"score_gpt":0.3634813343117108,"score_spread":0.2748813368119328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}